| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Baylor Genetics United States | 842 | 637 |
|
TP53 Sequence Analysis (Familial Mutation/Variant Analysis) Baylor Genetics United States | 9 | 1 |
|
Baylor Genetics United States | 9 | 1 |
|
TP53 Deletion/Duplication Analysis Baylor Genetics United States | 9 | 1 |
|
TP53 Comprehensive - Sequence & Deletion/Duplication Analysis Baylor Genetics United States | 9 | 1 |
|
PALB2 Gene Sequencing by Massively Parallel Sequencing (BCM-NGSSM) Baylor Genetics United States | 1 | 1 |
|
BRCA2 Sequence Analysis (Familial Mutation/Variant Analysis) Baylor Genetics United States | 1 | 1 |
|
BRCA1 Gene Sequencing by Massively Parallel Sequencing (BCM-NGSSM) Baylor Genetics United States | 1 | 1 |
|
PALB2 Sequence Analysis (Familial Mutation/Variant Analysis) Baylor Genetics United States | 1 | 1 |
|
BRCA1 Sequence Analysis (Familial Mutation/Variant Analysis) Baylor Genetics United States | 1 | 1 |
|
Hereditary Breast/Ovarian/Endometrial Cancer Panel Baylor Genetics United States | 1 | 23 |
|
BRCA2 Gene Sequencing by Massively Parallel Sequencing (BCM-NGSSM) Baylor Genetics United States | 1 | 1 |
|
BRIP1 Sequence Analysis (Familial Mutation/Variant Analysis) Baylor Genetics United States | 1 | 1 |
|
CHEK2 Gene Sequencing by Massively Parallel Sequencing (BCM-NGSSM) Baylor Genetics United States | 1 | 1 |
|
CHEK2 Sequence Analysis (Familial Mutation/Variant Analysis) Baylor Genetics United States | 1 | 1 |
|
BARD1 Gene Sequencing by Massively Parallel Sequencing (BCM-NGSSM) Baylor Genetics United States | 1 | 1 |
|
BARD1 Sequence Analysis (Familial Mutation/Variant Analysis) Baylor Genetics United States | 1 | 1 |
|
BRIP1 Gene Sequencing by Massively Parallel Sequencing (BCM-NGSSM) Baylor Genetics United States | 1 | 1 |
|
High Risk Hereditary Breast Cancer Panel Baylor Genetics United States | 1 | 7 |
|
PALB2 Sequence Analysis (Prenatal Sequence Analysis) Baylor Genetics United States | 1 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.